インスリン注入ポンプ市場- 世界の産業規模、シェア、動向、機会、予測、コンポーネント別、地域別、競合別、2019年～2029年

インスリン注入ポンプの世界市場は、2023年に14億5,000万米ドルと評価され、2029年までの予測期間にはCAGR 6.47％と堅調な成長が予測されています。

インスリン注入ポンプ市場は、技術の進歩、糖尿病有病率の増加、および改善された糖尿病管理ソリューションへの嗜好の高まりの合流によって力強い成長を経験しています。小型化、接続性の向上、持続グルコースモニタリング（CGM）システムの統合など、インスリンポンプの設計における技術革新は、糖尿病治療の展望を一変させました。これらのデバイスは、糖尿病患者により便利で柔軟なインスリン投与方法を提供し、血糖コントロールと全体的な生活の質の向上に貢献しています。糖尿病の世界の有病率の上昇は、座りがちなライフスタイルや食習慣の変化といった要因に起因しており、効果的で効率的なインスリン送達システムに対する大きな市場需要を生み出しています。患者やヘルスケアプロバイダーは、正確で個別化されたインスリン投与を提供するインスリン注入ポンプの利点を認識しつつあります。

インスリンポンプとCGM技術のコラボレーションは、リアルタイムグルコースモニタリングと自動インスリン調整をさらに促進し、より統合的で応答性の高い糖尿病管理への大きな飛躍を表しています。ヘルスケア専門家は、最適な血糖目標値を達成するための効果的なツールとして患者に推奨し、これらの機器の採用に影響を与える上で極めて重要な役割を果たしています。

市場促進要因

糖尿病有病率の増加

持続血糖モニタリングの統合

技術の進歩

生活の質の向上への注力

主な市場課題

コストと手頃な価格

デバイスの精度と信頼性

主な市場動向

デジタルヘルスプラットフォームとの統合

デジタルヘルスランドスケープが進化し続ける中、これらのプラットフォームとのシームレスな統合を優先するインスリン輸液ポンプが支持を集める可能性が高いです。

ウェアラブル技術との統合

セグメント別洞察

製品別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別（ポンプデバイス、輸液セット、リザーバー）
  • 地域別
  • 企業別（2023年）
• 市場マップ

第6章 北米のインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別
  • 国別
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのインスリン注入ポンプ市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • コンポーネント別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の開発（もしあれば）
• 合併買収（もしあれば）
• 製品発表（もしあれば）

第13章 インスリン注入ポンプの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Medtronic plc
• Insulet Corp
• Ascensia Diabetes Care Holdings AG
• Tandem Diabetes Care, Inc.
• Ypsomed Holding AG

第16章 戦略的提言

第17章 免責事項

Global Insulin Infusion Pumps Market was valued at USD 1.45 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.47% through 2029.The insulininfusionpumps market is experiencing robust growth driven by a confluence of technological advancements, increasing diabetes prevalence, and a growing preference for improved diabetes management solutions. Technological innovations in insulin pump design, such as smaller form factors, enhanced connectivity, and the integration of continuous glucose monitoring (CGM) systems, have revolutionized the landscape of diabetes care. These devices offer individuals with diabetes a more convenient and flexible method of insulin delivery, contributing to improved glycemic control and overall quality of life. The rising global prevalence of diabetes, attributed to factors like sedentary lifestyles and changing dietary habits, has created a substantial market demand for effective and efficient insulin delivery systems. Patients and healthcare providers are increasingly recognizing the benefits of insulin infusion pumps in providing precise and personalized insulin dosing.

The collaboration between insulin pumps and CGM technologies is further facilitating real-time glucose monitoring and automated insulin adjustments, representing a significant leap towards more integrated and responsive diabetes management. Healthcare professionals play a pivotal role in influencing the adoption of these devices, recommending them to patients as effective tools in achieving optimal glycemic targets.

Key Market Drivers

Increasing Diabetes Prevalence

The escalating prevalence of diabetes worldwide is a primary catalyst propelling the robust growth of the insulininfusionpumps market. As the global incidence of diabetes continues to rise, the demand for advanced and effective diabetes management solutions has intensified.insulininfusionpumpshave emerged as pivotal tools in this landscape, offering a sophisticated alternative to traditional insulin administration methods. Individuals diagnosed with diabetes increasingly seek solutions that provide precise and personalized insulin dosing while enhancing their overall quality of life. The convenience and flexibility offered byinsulininfusionpumpsresonate with patients looking to better manage their condition, leading to a significant surge in market adoption. Healthcare providers, recognizing the importance of maintaining optimal glycemic control, are more inclined to recommend these pumps as integral components of comprehensive diabetes care. Moreover, the integration of infusion pumps with continuous glucose monitoring systems represents a technological leap, enabling real-time data and automated adjustments, thus contributing to improved patient outcomes. The increasing prevalence of diabetes acts as a potent driver, underscoring the imperative for innovative and efficient insulin delivery systems. This trend not only reflects the immediate market needs but also underscores theinsulininfusionpumpsmarket's pivotal role in addressing the evolving challenges of diabetes management in the foreseeable future.

Continuous Glucose Monitoring Integration

Continuous Glucose Monitoring (CGM) integration stands as a transformative factor significantly influencing the growth trajectory of the globalinsulininfusionpumpsmarket. The seamless convergence of CGM technology with insulin pumps has ushered in a new era of precision and real-time diabetes management. By providing continuous and dynamic glucose level data, CGM integration enables users and healthcare providers to make informed decisions about insulin dosing, contributing to tighter glycemic control. This integration addresses a fundamental challenge in diabetes care, the need for timely and accurate information to adjust insulin delivery in response to fluctuating glucose levels. The synergy between CGM andinsulininfusionpumpsempowers patients with a comprehensive and automated approach to diabetes management, reducing the burden of constant monitoring and manual intervention. As a result, there is a growing demand for these integrated systems among individuals with diabetes seeking not only improved glucose control but also enhanced convenience in their daily lives. The market's response to CGM integration reflects a paradigm shift towards more proactive and personalized care, aligning with the broader trend of leveraging digital health solutions to optimize patient outcomes. Healthcare providers are increasingly recognizing the clinical value of these integrated systems, further fueling adoption rates. The CGM integration withininsulininfusionpumpsnot only addresses a critical need in diabetes care but also positions these technologies at the forefront of the evolving landscape of patient-centric, data-driven diabetes management solutions, driving sustained growth in the global insulin infusion pumps market.

Technological Advancements

Technological advancements are serving as a powerful catalyst for the dynamic growth of the globalinsulininfusionpumpsmarket. Continuous innovation in pump design and functionality has elevated these devices beyond mere insulin delivery tools, transforming them into sophisticated, user-friendly systems that cater to the evolving needs of individuals with diabetes. Smaller form factors, improved user interfaces, enhanced connectivity options, and the incorporation of smart features have collectively contributed to a paradigm shift in diabetes management. These technological strides not only enhance the precision and flexibility of insulin dosing but also significantly improve the overall user experience. Furthermore, the development of closed-loop systems, which integrate continuous glucose monitoring with insulin delivery in real-time, exemplifies a groundbreaking advancement that automates and optimizes glycemic control. Such innovations resonate with patients and healthcare providers alike, fostering increased adoption ofinsulininfusionpumpsas preferred alternatives to traditional injection methods. As these devices become more integrated with digital health ecosystems, allowing for seamless data sharing and remote monitoring, they further align with the contemporary trend of patient-centric and connected healthcare. The globalinsulininfusionpumpsmarket is thus propelled forward by a continuous wave of technological progress, promising not only improved clinical outcomes but also greater convenience and empowerment for individuals managing diabetes daily.

Focus on Improving Quality of Life

The focus on improving the quality of life for individuals with diabetes stands as a pivotal driver in the global insulin infusion pump market. Insulin pumps play a crucial role in enhancing the overall well-being of patients by providing a more flexible and convenient approach to insulin delivery. Unlike traditional injection methods, insulin infusion pumps offer users the ability to program and customize their insulin dosage, providing precise and continuous delivery throughout the day. This level of control not only contributes to better glycemic management but also reduces the burden of frequent injections, contributing to improved patient compliance and treatment adherence. The emphasis on enhancing the quality of life aligns with the broader goal of empowering individuals with diabetes to lead more normal and fulfilling lives, promoting independence and confidence in managing their condition. As technology continues to advance, insulin pumps are expected to evolve further, incorporating features that not only address medical needs but also prioritize the overall well-being and lifestyle preferences of the users.

Key Market Challenges

Costs and Affordability

insulininfusionpumpscan be expensive, posing a significant barrier to access for many individuals with diabetes. The high initial costs of acquiring these devices, coupled with ongoing expenses for supplies and maintenance, may limit their availability, especially in regions with limited healthcare resources or for individuals without adequate insurance coverage. Affordability challenges can result in unequal access to advanced diabetes management technologies, potentially exacerbating health disparities. This issue underscores the importance of developing strategies to make these technologies more cost-effective, exploring insurance coverage options, and advocating for policies that improve accessibility for a broader range of individuals managing diabetes.

Device Accuracy and Reliability

The effectiveness of diabetes management heavily relies on the precise and reliable delivery of insulin by these devices. However, several issues can compromise this accuracy. Infusion set failures, pump malfunctions, or inaccuracies in glucose readings from integrated continuous glucose monitoring (CGM) systems can occur. These technical challenges can lead to suboptimal glycemic control and potentially jeopardize the health of individuals with diabetes. Ensuring the dependability of insulininfusionpumps requires ongoing efforts from manufacturers to improve the design and quality control of these devices. Regular maintenance, proper training for users to troubleshoot common issues, and continuous advancements in technology to enhance the overall reliability of the pumps are essential in overcoming this challenge. Additionally, robust regulatory oversight is crucial to ensure that these devices meet rigorous standards for accuracy and safety.

Key Market Trends

Integration with Digital Health Platforms

Integration with digital health platforms represents a pivotal trend in the evolution of insulin infusion pumps, promising a transformative impact on diabetes management. This trend involves the seamless convergence of insulin pump technology with digital health solutions, creating a holistic and interconnected approach to diabetes care.

Digital integration offers a range of benefits, including real-time data monitoring, remote patient management, and improved communication between healthcare providers and patients. Insulin pumps equipped with digital connectivity can be synchronized with mobile apps or dedicated platforms, allowing users to track their glucose levels, insulin doses, and other relevant metrics effortlessly. This continuous data stream empowers patients to make informed decisions about their treatment, fostering a proactive approach to diabetes management.

Furthermore, the integration of insulin pumps with digital health platforms facilitates remote monitoring by healthcare professionals. This real-time access to patient data enables timely interventions and adjustments to treatment plans, enhancing overall care quality. Telemedicine consultations become more streamlined as healthcare providers can remotely assess patients' glucose data, offer guidance, and make necessary adjustments to insulin regimens.

The comprehensive digital ecosystem also promotes patient engagement and education. Users can access educational resources, receive personalized insights based on their data, and participate in virtual communities for support. This interconnectedness creates a supportive environment for individuals managing diabetes, fostering a sense of community and shared experiences.

In addition to improving patient outcomes, the integration of insulin pumps with digital platforms contributes to research and population health management. Aggregated, anonymized data from a diverse user base can inform advancements in diabetes treatment protocols, paving the way for evidence-based innovations.

As the digital health landscape continues to evolve, insulin infusion pumps that prioritize seamless integration with these platforms are likely to gain traction.

Wearable Technology Integration

The integration of technological advancements, particularly the incorporation of wearable technology, stands as a crucial trend influencing the future of insulin infusion pumps. This trend involves seamlessly merging insulin pump functionalities with popular wearable devices such as smartwatches and health trackers. By doing so, users can not only monitor glucose levels but also gain insights from additional health metrics provided by the wearables, such as physical activity, heart rate, and sleep patterns. The synergy between insulin pumps and wearables aims to create a more holistic approach to diabetes management, enabling users and healthcare professionals to make well-informed decisions based on a comprehensive set of health data. This integration enhances the user experience, promotes continuous monitoring, and fosters a proactive approach to diabetes care, aligning with the broader trend of incorporating technology for more personalized and interconnected healthcare solutions.

Segmental Insights

ProductInsights

In 2023, the pump device segment dominated the Insulin Infusion Pumps market by product type and is predicted to continue expanding over the coming years.The significant market share can be attributed to the pivotal role that pump devices play in offering precise and programmable insulin delivery, addressing the evolving needs of individuals managing diabetes. Insulin pump devices provide a convenient and efficient alternative to traditional injection methods, offering users greater control over their insulin dosages and allowing for more flexible and personalized management. The continuous advancements in pump device technology, including improvements in design, user interfaces, and connectivity features, have fueled their popularity among both healthcare providers and patients. Moreover, the integration of pump devices with continuous glucose monitoring systems has further enhanced their appeal, offering a more comprehensive approach to diabetes management. As the prevalence of diabetes continues to rise globally, the demand for effective and user-friendly insulin delivery systems is expected to drive the expansion of the pump device segment. The anticipated increase in diabetes cases, coupled with ongoing technological innovations in pump device functionalities, positions this segment for continued dominance and growth in the insulin infusion pumps market. Additionally, as healthcare providers and patients increasingly recognize the benefits of pump devices in achieving optimal glycaemic control, their market share is likely to remain robust, solidifying their position as a cornerstone in the evolving landscape of diabetes care.

Regional Insights

The North America region has established itself as the leader in the Insulin Infusion Pumps Market in 2023.The region boasts a high prevalence of diabetes, with a substantial portion of the population requiring advanced and effective diabetes management solutions. This elevated disease burden creates a robust market demand for insulin infusion pumps.

North America is at the forefront of technological advancements and healthcare innovation. The region is home to many key players in the medical device industry, including manufacturers of insulin infusion pumps. The continuous research and development efforts in the field of diabetes care, along with a strong regulatory environment, contribute to the availability and adoption of cutting-edge insulin delivery technologies.

Well-established healthcare infrastructure and a high level of awareness among both healthcare professionals and patients contribute to the widespread adoption of insulin infusion pumps. The accessibility of these devices, coupled with favorable reimbursement policies in certain parts of North America, facilitates their integration into diabetes management plans.

Moreover, the proactive approach of healthcare providers in North America toward embracing new and advanced medical technologies plays a crucial role. This includes the incorporation of integrated systems, such as insulin pumps with continuous glucose monitoring, providing patients with more comprehensive and real-time management options.

Additionally, a robust healthcare ecosystem that encourages collaboration between healthcare providers, manufacturers, and regulatory bodies further propels the dominance of the North American region in the Insulin Infusion Pumps Market. The presence of key opinion leaders, research institutions, and diabetes care organizations contributes to the continuous improvement and adoption of insulin infusion pump technologies.

Key Market Players

Medtronic plc

Insulet Corporation

Ascensia Diabetes Care Holdings AG

Tandem Diabetes Care, Inc.

Ypsomed Holding AG

Report Scope:

In this report, the Insulin Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Insulin Infusion Pumps Market,By Component:

Pump Device

Infusion Set

Reservoir

Insulin Infusion Pumps Market, By Region:

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• Italy
• France
• Spain

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia

South America

• Brazil
• Argentina
• Colombia

Middle East Africa

• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Insulin Infusion Pumps Market.

Available Customizations:

Global Insulin Infusion Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validations
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.GlobalInsulin Infusion Pumps MarketOutlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Component (Pump Device, Infusion Set, and Reservoir)
  • 5.2.2.By Region
  • 5.2.3.By Company (2023)
• 5.3.Market Map

6.North America Insulin Infusion Pumps Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Component
  • 6.2.2.By Country
• 6.3.North America: Country Analysis
  • 6.3.1.United States Insulin Infusion Pumps Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Component
  • 6.3.2.Canada Insulin Infusion Pumps Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Component
  • 6.3.3.Mexico Insulin Infusion Pumps Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Component

7.Europe Insulin Infusion Pumps Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Component
  • 7.2.2.By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.Germany Insulin Infusion Pumps Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Component
  • 7.3.2.United Kingdom Insulin Infusion Pumps Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Component
  • 7.3.3.Italy Insulin Infusion Pumps Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Component
  • 7.3.4.France Insulin Infusion Pumps Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Component
  • 7.3.5.Spain Insulin Infusion Pumps Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Component

8.Asia-Pacific Insulin Infusion Pumps Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Component
  • 8.2.2.By Country
• 8.3.Asia-Pacific: Country Analysis
  • 8.3.1.China Insulin Infusion Pumps Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Component
  • 8.3.2.India Insulin Infusion Pumps Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Component
  • 8.3.3.Japan Insulin Infusion Pumps Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Component
  • 8.3.4.South Korea Insulin Infusion Pumps Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Component
  • 8.3.5.Australia Insulin Infusion Pumps Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Component

9.South America Insulin Infusion Pumps Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Component
  • 9.2.2.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Insulin Infusion Pumps Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Component
  • 9.3.2.Argentina Insulin Infusion Pumps Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Component
  • 9.3.3.Colombia Insulin Infusion Pumps Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Component

10.Middle East and Africa Insulin Infusion Pumps Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1.By Component
  • 10.2.2.By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Insulin Infusion Pumps Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Component
  • 10.3.2.Saudi Arabia Insulin Infusion Pumps Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Component
  • 10.3.3.UAE Insulin Infusion Pumps Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Component

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Development (If Any)
• 12.2.Mergers Acquisitions (If Any)
• 12.3. Product Launches (If Any)

13.Global Insulin Infusion Pumps Market: SWOT Analysis

14.Porter's Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Products

15.Competitive Landscape

• 15.1.Medtronic plc
  • 15.1.1.Business Overview
  • 15.1.2.Product Service Offerings
  • 15.1.3.Recent Developments
  • 15.1.4.Key Personnel Details
  • 15.1.5.SWOT Analysis
• 15.2.Insulet Corp
• 15.3.Ascensia Diabetes Care Holdings AG
• 15.4.Tandem Diabetes Care, Inc.
• 15.5.Ypsomed Holding AG

16.Strategic Recommendations

17.About Us Disclaimer